CD14 and rheumatoid arthritis: Thus, miR-155 overexpression promotes a pro-inflammatory phenotype in monocytes/macrophages, whereas in vitro treatment of RA patients’ synovial fluid CD14+ cells with miR-155 antagonist de-repressed SHIP-1, inhibited the production of TNF (57) and restored cellular homeostasis.